Baroreflex function in streptozotocin (STZ) induced diabetic rats

Area of Science:

• Cardiovascular Physiology
• Renal Sympathetic Nervous System
• Diabetes Mellitus Research

Background:

• Diabetes mellitus is associated with significant cardiovascular complications.
• Alterations in autonomic nervous system function, particularly sympathetic activity, are common in diabetes.
• The impact of diabetes on baroreflex control of renal sympathetic nerve activity and heart rate requires further investigation.

Purpose of the Study:

• To investigate whether renal sympatho-inhibition and bradycardia responses to acute increases in arterial pressure are altered in streptozotocin-induced diabetic rats.
• To assess baroreflex function in early-stage diabetes.
• To examine the roles of angiotensin II and vasopressin in modulating baroreflexes in diabetic conditions.

Main Methods:

• Measurement of integrated renal sympathetic nerve activity and heart rate in anesthetized control and diabetic rats.
• Induction of diabetes using streptozotocin (STZ) in Sprague Dawley rats.
• Acute elevation of blood pressure to assess baroreflex responses; administration of enalapril and vasopressin to evaluate specific pathway effects.

Main Results:

• Blood glucose levels were significantly elevated in diabetic rats.
• Baroreflex changes in renal nerve activity and heart rate were not significantly different between diabetic and control rats.
• Renal sympatho-inhibition during volume expansion was blunted in diabetic rats; vasopressin failed to potentiate the baroreflex in diabetic rats.

Conclusions:

• Baroreflex function remains normal in the early phase of streptozotocin-induced diabetes, contrasting with impaired volume reflexes.
• Blocking the angiotensin II system does not affect baroreflex function in diabetic rats.
• The potentiating effect of vasopressin on the baroreflex is lost in diabetic rats compared to euglycemic controls.